ROLE OF CONCOMITANT IMMUNOSUPPRESSION IN THE EFFICACY AND SAFETY OF USTEKINUMAB: POST-HOC ANALYSES OF UNITI

(1) University of Birmingham, Institute of Immunology and Immunotherapy,Birmingham,Canada

(2) Janssen Inc,Toronto,Canada

(3) Janssen Research & Development, LLC,Spring House,United States

(4) Janssen Scientific Affairs, LLC,Horsham,United States

(5) University Hospital Gasthuisberg,Leuven,Belgium

(6) Northwestern University Feinberg School of Medicine,Chicago,United States



This item was part of UEG Week 2018

This item can be cited as: United European Gastroenterology Journal 2018; 6 (Supplement 1)

You may be interested in:

Mucosal Healing in Crohn´s Disease and Ulcerative Colitis How should it be assessed and how important is it
English, Presentation, Clinical aspects, Medical management, Colon, Capsule technologies, Capsule Endoscopy, Investigation and Diagnosis, Inflammatory bowel disease, Colonoscopy and sigmoidoscopy, Small intestine, Endoscopic scoring systems, 2010

Categorisation:

  • Format
    • Abstract
  • Year
    • 2018